genetix biotherapeutics

Private

Last Round

Buyout/LBO

Jun 2, 2025

Est. Valuation

$45M

Total Funding Raised

$1.66B

Company Overview

A commercial-stage biotechnology company that develops and delivers gene therapies for severe rare diseases.

Historical view of private secondary pricing and transaction trends.

Proprietary index based on bid/ask volume and sentiment.

Track how buyer interest and sentiment changes over time.

Related companies by embedding similarity.

Access detailed peer comparisons, multiples, and valuation benchmarks.

Historical fundraising activity

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

SEC and related filings with document metadata.

Common questions about genetix biotherapeutics's valuation, stock price, and market status.

Headquarters—

Year Founded1992

Last FundingJun 2, 2025

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.